Self-Assembly of Reactive Linear Cu₃ Building Blocks for Supramolecular Coordination Chemistry and Their Reactivity toward E_<i>n</i> Ligand Complexes by Martin Fleischmann (2544508)

“…Reactions of <b>2a</b>–<b>c</b> with <i>cyclo</i>-E₅ complexes [Cp*Fe­(η⁵-E₅)] (E = P (<b>C1</b>), As (<b>C2</b>)) led to the isolation of one-dimensional coordination polymers [Cu₃(μ-X)₂(μ-dpmp)₂(μ,η¹:η¹-L)]_<i>n</i>[BF₄]_<i>n</i> (<b>8a</b>–<b>b</b>: X = Cl–Br, L = <b>C1</b>; <b>9</b>: X = Cl, L = <b>C2</b>) and symmetrically substituted complex [Cu₃(μ-I)₂(μ-dpmp)₂(η¹-<b>C1</b>)₂]⁺ (<b>10</b>). …”

Self-Assembly of Reactive Linear Cu₃ Building Blocks for Supramolecular Coordination Chemistry and Their Reactivity toward E_<i>n</i> Ligand Complexes by Martin Fleischmann (2544508)

“…Reactions of <b>2a</b>–<b>c</b> with <i>cyclo</i>-E₅ complexes [Cp*Fe­(η⁵-E₅)] (E = P (<b>C1</b>), As (<b>C2</b>)) led to the isolation of one-dimensional coordination polymers [Cu₃(μ-X)₂(μ-dpmp)₂(μ,η¹:η¹-L)]_<i>n</i>[BF₄]_<i>n</i> (<b>8a</b>–<b>b</b>: X = Cl–Br, L = <b>C1</b>; <b>9</b>: X = Cl, L = <b>C2</b>) and symmetrically substituted complex [Cu₃(μ-I)₂(μ-dpmp)₂(η¹-<b>C1</b>)₂]⁺ (<b>10</b>). …”

Self-Assembly of Reactive Linear Cu₃ Building Blocks for Supramolecular Coordination Chemistry and Their Reactivity toward E_<i>n</i> Ligand Complexes by Martin Fleischmann (2544508)

“…Reactions of <b>2a</b>–<b>c</b> with <i>cyclo</i>-E₅ complexes [Cp*Fe­(η⁵-E₅)] (E = P (<b>C1</b>), As (<b>C2</b>)) led to the isolation of one-dimensional coordination polymers [Cu₃(μ-X)₂(μ-dpmp)₂(μ,η¹:η¹-L)]_<i>n</i>[BF₄]_<i>n</i> (<b>8a</b>–<b>b</b>: X = Cl–Br, L = <b>C1</b>; <b>9</b>: X = Cl, L = <b>C2</b>) and symmetrically substituted complex [Cu₃(μ-I)₂(μ-dpmp)₂(η¹-<b>C1</b>)₂]⁺ (<b>10</b>). …”

Self-Assembly of Reactive Linear Cu₃ Building Blocks for Supramolecular Coordination Chemistry and Their Reactivity toward E_<i>n</i> Ligand Complexes by Martin Fleischmann (2544508)

“…Reactions of <b>2a</b>–<b>c</b> with <i>cyclo</i>-E₅ complexes [Cp*Fe­(η⁵-E₅)] (E = P (<b>C1</b>), As (<b>C2</b>)) led to the isolation of one-dimensional coordination polymers [Cu₃(μ-X)₂(μ-dpmp)₂(μ,η¹:η¹-L)]_<i>n</i>[BF₄]_<i>n</i> (<b>8a</b>–<b>b</b>: X = Cl–Br, L = <b>C1</b>; <b>9</b>: X = Cl, L = <b>C2</b>) and symmetrically substituted complex [Cu₃(μ-I)₂(μ-dpmp)₂(η¹-<b>C1</b>)₂]⁺ (<b>10</b>). …”

Self-Assembly of Reactive Linear Cu₃ Building Blocks for Supramolecular Coordination Chemistry and Their Reactivity toward E_<i>n</i> Ligand Complexes by Martin Fleischmann (2544508)

“…Reactions of <b>2a</b>–<b>c</b> with <i>cyclo</i>-E₅ complexes [Cp*Fe­(η⁵-E₅)] (E = P (<b>C1</b>), As (<b>C2</b>)) led to the isolation of one-dimensional coordination polymers [Cu₃(μ-X)₂(μ-dpmp)₂(μ,η¹:η¹-L)]_<i>n</i>[BF₄]_<i>n</i> (<b>8a</b>–<b>b</b>: X = Cl–Br, L = <b>C1</b>; <b>9</b>: X = Cl, L = <b>C2</b>) and symmetrically substituted complex [Cu₃(μ-I)₂(μ-dpmp)₂(η¹-<b>C1</b>)₂]⁺ (<b>10</b>). …”

Self-Assembly of Reactive Linear Cu₃ Building Blocks for Supramolecular Coordination Chemistry and Their Reactivity toward E_<i>n</i> Ligand Complexes by Martin Fleischmann (2544508)

“…Reactions of <b>2a</b>–<b>c</b> with <i>cyclo</i>-E₅ complexes [Cp*Fe­(η⁵-E₅)] (E = P (<b>C1</b>), As (<b>C2</b>)) led to the isolation of one-dimensional coordination polymers [Cu₃(μ-X)₂(μ-dpmp)₂(μ,η¹:η¹-L)]_<i>n</i>[BF₄]_<i>n</i> (<b>8a</b>–<b>b</b>: X = Cl–Br, L = <b>C1</b>; <b>9</b>: X = Cl, L = <b>C2</b>) and symmetrically substituted complex [Cu₃(μ-I)₂(μ-dpmp)₂(η¹-<b>C1</b>)₂]⁺ (<b>10</b>). …”

Self-Assembly of Reactive Linear Cu₃ Building Blocks for Supramolecular Coordination Chemistry and Their Reactivity toward E_<i>n</i> Ligand Complexes by Martin Fleischmann (2544508)

“…Reactions of <b>2a</b>–<b>c</b> with <i>cyclo</i>-E₅ complexes [Cp*Fe­(η⁵-E₅)] (E = P (<b>C1</b>), As (<b>C2</b>)) led to the isolation of one-dimensional coordination polymers [Cu₃(μ-X)₂(μ-dpmp)₂(μ,η¹:η¹-L)]_<i>n</i>[BF₄]_<i>n</i> (<b>8a</b>–<b>b</b>: X = Cl–Br, L = <b>C1</b>; <b>9</b>: X = Cl, L = <b>C2</b>) and symmetrically substituted complex [Cu₃(μ-I)₂(μ-dpmp)₂(η¹-<b>C1</b>)₂]⁺ (<b>10</b>). …”

Image_8_Pharmacokinetic Behavior of Vincristine and Safety Following Intravenous Administration of Vincristine Sulfate Liposome Injection in Chinese Patients With Malignant Lymphom... by Fen Yang (287005)

“…</p><p>Results: In this phase Ia study, a total of eight subjects participated. VCR elimination from the circulation after injection of VSLI was characterized by a significantly increased maximum concentration (C_max, 86.6 ng/mL) and plasma area under the plasma concentration-time curve from zero to infinity (AUC_0-Inf, 222.1 ng/mL h), markedly decreased distribution volume (V_z, 224.1 L) and plasma clearance (CL, 8.9 L/h) compared to lower C_max (26.6 ng/mL) and AUC_0-Inf (95.1 ng/mL h), larger V_z (688.8 L) and CL (22.1 L/h) for VSI. …”

Image_1_Pharmacokinetic Behavior of Vincristine and Safety Following Intravenous Administration of Vincristine Sulfate Liposome Injection in Chinese Patients With Malignant Lymphom... by Fen Yang (287005)

“…</p><p>Results: In this phase Ia study, a total of eight subjects participated. VCR elimination from the circulation after injection of VSLI was characterized by a significantly increased maximum concentration (C_max, 86.6 ng/mL) and plasma area under the plasma concentration-time curve from zero to infinity (AUC_0-Inf, 222.1 ng/mL h), markedly decreased distribution volume (V_z, 224.1 L) and plasma clearance (CL, 8.9 L/h) compared to lower C_max (26.6 ng/mL) and AUC_0-Inf (95.1 ng/mL h), larger V_z (688.8 L) and CL (22.1 L/h) for VSI. …”

Image_6_Pharmacokinetic Behavior of Vincristine and Safety Following Intravenous Administration of Vincristine Sulfate Liposome Injection in Chinese Patients With Malignant Lymphom... by Fen Yang (287005)

“…</p><p>Results: In this phase Ia study, a total of eight subjects participated. VCR elimination from the circulation after injection of VSLI was characterized by a significantly increased maximum concentration (C_max, 86.6 ng/mL) and plasma area under the plasma concentration-time curve from zero to infinity (AUC_0-Inf, 222.1 ng/mL h), markedly decreased distribution volume (V_z, 224.1 L) and plasma clearance (CL, 8.9 L/h) compared to lower C_max (26.6 ng/mL) and AUC_0-Inf (95.1 ng/mL h), larger V_z (688.8 L) and CL (22.1 L/h) for VSI. …”

Image_7_Pharmacokinetic Behavior of Vincristine and Safety Following Intravenous Administration of Vincristine Sulfate Liposome Injection in Chinese Patients With Malignant Lymphom... by Fen Yang (287005)

“…</p><p>Results: In this phase Ia study, a total of eight subjects participated. VCR elimination from the circulation after injection of VSLI was characterized by a significantly increased maximum concentration (C_max, 86.6 ng/mL) and plasma area under the plasma concentration-time curve from zero to infinity (AUC_0-Inf, 222.1 ng/mL h), markedly decreased distribution volume (V_z, 224.1 L) and plasma clearance (CL, 8.9 L/h) compared to lower C_max (26.6 ng/mL) and AUC_0-Inf (95.1 ng/mL h), larger V_z (688.8 L) and CL (22.1 L/h) for VSI. …”

Image_3_Pharmacokinetic Behavior of Vincristine and Safety Following Intravenous Administration of Vincristine Sulfate Liposome Injection in Chinese Patients With Malignant Lymphom... by Fen Yang (287005)

“…</p><p>Results: In this phase Ia study, a total of eight subjects participated. VCR elimination from the circulation after injection of VSLI was characterized by a significantly increased maximum concentration (C_max, 86.6 ng/mL) and plasma area under the plasma concentration-time curve from zero to infinity (AUC_0-Inf, 222.1 ng/mL h), markedly decreased distribution volume (V_z, 224.1 L) and plasma clearance (CL, 8.9 L/h) compared to lower C_max (26.6 ng/mL) and AUC_0-Inf (95.1 ng/mL h), larger V_z (688.8 L) and CL (22.1 L/h) for VSI. …”

Image_2_Pharmacokinetic Behavior of Vincristine and Safety Following Intravenous Administration of Vincristine Sulfate Liposome Injection in Chinese Patients With Malignant Lymphom... by Fen Yang (287005)

“…</p><p>Results: In this phase Ia study, a total of eight subjects participated. VCR elimination from the circulation after injection of VSLI was characterized by a significantly increased maximum concentration (C_max, 86.6 ng/mL) and plasma area under the plasma concentration-time curve from zero to infinity (AUC_0-Inf, 222.1 ng/mL h), markedly decreased distribution volume (V_z, 224.1 L) and plasma clearance (CL, 8.9 L/h) compared to lower C_max (26.6 ng/mL) and AUC_0-Inf (95.1 ng/mL h), larger V_z (688.8 L) and CL (22.1 L/h) for VSI. …”

Data_Sheet_1_First-in-human pilot trial of combined intracoronary and intravenous mesenchymal stem cell therapy in acute myocardial infarction.docx by Lien-Cheng Hsiao (13217106)

“…The NT-proBNP level decreased (1362 ± 1801 vs. 109 ± 115 pg/mL, p = 0.0313), the LVEF increased (52.67 ± 12.75% vs. 62.47 ± 17.35%, p = 0.0246), and the wall motion score decreased (26.33 ± 5.57 vs. 22.33 ± 5.85, p = 0.0180) at the 12-month follow-up compared to the baseline values. …”

Image_4_Pharmacokinetic Behavior of Vincristine and Safety Following Intravenous Administration of Vincristine Sulfate Liposome Injection in Chinese Patients With Malignant Lymphom... by Fen Yang (287005)

“…</p><p>Results: In this phase Ia study, a total of eight subjects participated. VCR elimination from the circulation after injection of VSLI was characterized by a significantly increased maximum concentration (C_max, 86.6 ng/mL) and plasma area under the plasma concentration-time curve from zero to infinity (AUC_0-Inf, 222.1 ng/mL h), markedly decreased distribution volume (V_z, 224.1 L) and plasma clearance (CL, 8.9 L/h) compared to lower C_max (26.6 ng/mL) and AUC_0-Inf (95.1 ng/mL h), larger V_z (688.8 L) and CL (22.1 L/h) for VSI. …”

Table1_The Expression of Cytokine Profiles and Related Receptors in Idiopathic Inflammatory Myopathies.docx by Junyu Zhou (1548346)

“…The number of IL18R1⁺CD4⁺ cells was increased while IL18R1⁺CD8⁺ cells was decreased in peripheral blood of anti-MDA5 patients.…”

Post-tetanic relaxation patterns. by Inès Barthélémy (119037)

“…The 100 ms relaxation level was significantly increased at 4 (D) and 6 months (E) in the treated dogs. The mean post-tetanic residual contraction was increased in untreated GRMD dogs, and decreased around healthy levels in treated GRMD dogs; however, these differences were not significant. …”

TGFβR1 kinase activity is necessary for VE-cadherin expression. by Priya Prahalad (50952)

“…Treatment with SB431542 decreases PAI-1 activity, confirming TGFβR1 blockade (b).The samples are as follows: 1 - Control; 2 - RA; 3 - Control, 10 µM SB431542; 4 - RA, 10 µM SB431542; 5 - Control - 50 µM SB431542; 6 - RA, 50 µM SB431542. …”

Baseline characteristics of participants. by Mei Zhou (269746)

“…Linear regression indicated a positive association between intervention and expenditures (0.5%increase). …”

The framework diagram of this study. by Mei Zhou (269746)

“…Linear regression indicated a positive association between intervention and expenditures (0.5%increase). …”